In many countries, health care reimbursements for drugs are directly related to their value or net health benefits in treating disease. But a new study shows that’s not the case in the United States.
In many countries, health care reimbursements for drugs are directly related to their value or net health benefits in treating disease. But a new study shows that’s not the case in the United States.